Completeness and concordancy of WHO grade assignment for brain and central nervous system tumors in the United States, 2004–2011

Journal of Neuro-Oncology

Volumn 123, Issue 1, 2015, Pages 43-51

  Lym, Ryan L ^a   Ostrom, Quinn T ^a,b   Kruchko, Carol ^b   Couce, Marta ^a,c   Brat, Daniel J ^d   Louis, David N ^e   Barnholtz Sloan, Jill S ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Central Brain Tumor Registry of the United States   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cancer registry; Central nervous system tumors; Neuropathology; World Health Organization (WHO) grade; World Health Organization (WHO) histological type

Indexed keywords

ANAPLASTIC EPENDYMOMA; ANAPLASTIC MENINGIOMA; ANAPLASTIC OLIGOASTROCYTOMA; ARTICLE; ASTROCYTOMA; ATYPICAL MENINGIOMA; BRAIN TUMOR; CANCER REGISTRY; CENTRAL NERVOUS SYSTEM TUMOR; CRANIOPHARYNGIOMA; DISEASE SURVEILLANCE; EPENDYMOMA; GLIOBLASTOMA; HEMANGIOBLASTOMA; HISTOPATHOLOGY; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES FOR ONCOLOGY; MALIGNANT MENINGIOMA; MEDULLOBLASTOMA; MENINGIOMA; OLIGODENDROGLIOMA; PILOCYTIC ASTROCYTOMA; TREND STUDY; TUMOR CLASSIFICATION; UNITED STATES; WORLD HEALTH ORGANIZATION; BRAIN NEOPLASMS; CANCER GRADING; CENTRAL NERVOUS SYSTEM NEOPLASMS; CLASSIFICATION; PATHOLOGY; PROGNOSIS; TIME FACTOR;

BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM NEOPLASMS; HUMANS; NEOPLASM GRADING; PROGNOSIS; SEER PROGRAM; TIME FACTORS; UNITED STATES; WORLD HEALTH ORGANIZATION;

EID: 84929840891     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-015-1775-4     Document Type: Article

References (23)

1. Zulch KJ (1979) Histological typing of tumours of the central nervous system. International histological classification of tumours, no 21. World Health Organization, Geneva
2. Kleihues P, Burger PC, Scheithauer BW, Zulch KJ (1993) Histological typing of tumours of the central nervous system, 2nd edn. Berlin, Springer-Verlag
3. Kleihues P, Cavenee WK, International Agency for Research on Cancer (2000) Pathology and genetics of tumours of the nervous system. IARC Press, Lyon
4. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (2007) WHO classification of tumours of the central nervous system. World Health Organization classification of tumours, 4th edn. International Agency for Research on Cancer, Lyon
5. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109. doi:10.1007/s00401-007-0243-4
6. Pollo B (2011) Neuropathological diagnosis of brain tumours. Neurol Sci 32(Suppl 2):S209–S211. doi:10.1007/s10072-011-0802-2
7. Brat DJ, Parisi JE, Kleinschmidt-DeMasters BK, Yachnis AT, Montine TJ, Boyer PJ, Powell SZ, Prayson RA, McLendon RE, CoAP Neuropathology Committee (2008) Surgical neuropathology update: a review of changes introduced by the WHO classification of tumours of the central nervous system, 4th edition. Arch Pathol Lab Med 132:993–1007. doi:10.1043/1543-2165
8. Parisi JE, Miller DV, Boyer PJ, Brat DJ, Cochran EJ, Cohen ML, Demasters BK, Dolinak D, McComb RD, McLendon RE, Powell SZ, Prayson RA, Vinters HV, Yachnis AT, Members of Cancer Committee CoAP (2008) Protocol for the examination of specimens from patients with tumors of the brain/spinal cord. Arch Pathol Lab Med 132: 907–912 doi:10.1043/1543-2165
9. Combs SE, Schulz-Ertner D, Debus J, von Deimling A, Hartmann C (2011) Improved correlation of the neuropathologic classification according to adapted world health organization classification and outcome after radiotherapy in patients with atypical and anaplastic meningiomas. Int J Radiat Oncol Biol Phys 81:1415–1421. doi:10.1016/j.ijrobp.2010.07.039
10. Willis J, Smith C, Ironside JW, Erridge S, Whittle IR, Everington D (2005) The accuracy of meningioma grading: a 10-year retrospective audit. Neuropathol Appl Neurobiol 31:141–149. doi:10.1111/j.1365-2990.2004.00621.x
11. Kruchko C, Dolecek TA, McCarthy BJ (2011) A Review of the Collection of WHO Grade for Brain and CNS Tumors in Cancer Registration. Poster presented at: Society for Neuro-Oncology Annual Scientific Meeting and Education Day; Nov 17–20, 2011. Orange County, California
12. Surveillance Research Program—National Cancer Institute (2010) SEER… as a Research Resource. http://seer.cancer.gov/about/factsheets/SEER_Research_Brochure.pdf
13. Surveillance Epidemiology and End Results (SEER) Program SEER*Stat Database: Incidence—SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2013 Sub (1973-2011 varying)—Linked To County Attributes—Total U.S., 1969-2012 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2014, based on the November 2013 submission
14. (2002) Benign Brain Tumor Cancer Registries Amendment Act. http://www.gpo.gov/fdsys/pkg/PLAW-107publ260/pdf/PLAW-107publ260.pdf. Accessed 4 June 2014
15. Surveillance Epidemiology and End Results (SEER) Program (2013) SEER Program Coding and Staging Manual 2013. http://seer.cancer.gov/archive/manuals/2013/SPCSM_2013_maindoc.pdf. Accessed 4 June 2014
16. Collaborative Stage Data Collection System (2013) Brain: CS Site-Specific Factor 1, World Health Organization (WHO) Grade Classification. http://web2.facs.org/cstage0205/brain/Brain_jpo.html. Accessed 5 June 2014
17. Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS (2014) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro Oncol 16: iv1–iv63. doi:10.1093/neuonc/nou223
18. Surveillance Epidemiology and End Results (SEER) Program SEER Training Modules, Cancer Diagnosis. U. S. National Institutes of Health, National Cancer Institute. http://training.seer.cancer.gov/. Accessed 20 June 2014
19. Louis DN, Perry A, Burger P, Ellison DW, Reifenberger G, von Deimling A, Aldape K, Brat D, Collins VP, Eberhart C, Figarella-Branger D, Fuller GN, Giangaspero F, Giannini C, Hawkins C, Kleihues P, Korshunov A, Kros JM, Beatriz Lopes M, Ng HK, Ohgaki H, Paulus W, Pietsch T, Rosenblum M, Rushing E, Soylemezoglu F, Wiestler O, Wesseling P (2014) International society of neuropathology-haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathol 24:429–435. doi:10.1111/bpa.12171
20. Detti B, Scoccianti S, Di Cataldo V, Monteleone E, Cipressi S, Bordi L, Pellicano G, Gadda D, Saieva C, Greto D, Pecchioli G, Buccoliero A, Ceroti M, Ammannati F, Biti G (2013) Atypical and malignant meningioma: outcome and prognostic factors in 68 irradiated patients. J Neurooncol 115:421–427. doi:10.1007/s11060-013-1239-7
21. Simon M, Bostrom J, Koch P, Schramm J (2006) Interinstitutional variance of postoperative radiotherapy and follow up for meningiomas in Germany: impact of changes of the WHO classification. J Neurol Neurosurg Psychiatry 77:767–773. doi:10.1136/jnnp.2005.077974
22. Yang SY, Park CK, Park SH, Kim DG, Chung YS, Jung HW (2007) Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features. J Neurol Neurosurg Psychiatry 79:574–580. doi:10.1136/jnnp.2007.121582
23. Rosenberg LA, Prayson RA, Lee J, Reddy C, Chao ST, Barnett GH, Vogelbaum MA, Suh JH (2009) Long-term experience with world health organization grade III (malignant) meningiomas at a single institution. Int J Radiat Oncol Biol Phys 74:427–432. doi:10.1016/j.ijrobp.2008.08.018